Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

RECRUITING NA

Treatment of the Biceps With Concomitant Supraspinatus Tears

NCT05660031 · View on ClinicalTrials.gov ↗

Study Summary

The long head of the biceps (LHB) tendon is thought to be a common source of shoulder pain and dysfunction in patients with rotator cuff pathology. Tenotomy and tenodesis have been shown to produce favourable and comparable results in treating LHB lesions, but a controversy still exists regarding the treatment of choice. Some suggest that tenotomy should be reserved for older, low-demand patients, while tenodesis should be performed in younger patients and those who engage in heavy labor. Proponents of tenotomy suggest that this is a technically easy procedure that leads to easy rehabilitation and fast return to activity with a low complication and reoperation rate. However, those who support LHB tenodesis list good preservation of elbow flexion and supination strength, improvement of functional scores, elimination of pain, and avoidance of cosmetic deformity as benefits of the procedure. Alternatively, the LHB can be maintained in the joint without tenodesis or tenotomy. In fact, it has not been clearly shown that LHB tenodesis or tenotomy leads to improved outcomes compared to leaving the biceps tendon intact.

Conditions Studied

Interventions

  • PROCEDURE LHB Tenotomy
  • PROCEDURE LHB Tenodesis

Study Locations (4)

Michigan

  • Sports Medicine and Shoulder Surgery, University of Michigan — Ann Arbor

Oregon

  • Oregon Health & Science University — Portland

Alberta

  • Group 23 Sports Medicine — Calgary

Canton of Geneva

  • la Tour hospital — Meyrin

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2021-06-01
Est. Completion 2026-06-01
Phase NA

Sponsor

La Tour Hospital

2 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05660031

The ClinicalTrials.gov registry entry for NCT05660031 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is La Tour Hospital, which has 2 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 1 condition, with Supraspinatus Tear appearing as the primary indexed condition, and to 2 interventions — of which LHB Tenotomy is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT05660031 reports 4 study locations spanning 4 distinct geographic areas — top geographies include Michigan, Oregon, Alberta. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT05660031 about?

NCT05660031 is a clinical study titled "Treatment of the Biceps With Concomitant Supraspinatus Tears". The long head of the biceps (LHB) tendon is thought to be a common source of shoulder pain and dysfunction in patients with rotator cuff pathology. Tenotomy and tenodesis have been shown to produce favourable and comparable results in treating LHB lesions, but a controversy still exists regarding th...

What is the current status of trial NCT05660031?

This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2021-06-01. Estimated completion is 2026-06-01.

What conditions does trial NCT05660031 study?

This clinical trial studies the following conditions: Supraspinatus Tear. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT05660031?

The interventions under investigation include: LHB Tenotomy (PROCEDURE), LHB Tenodesis (PROCEDURE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT05660031?

This trial is sponsored by La Tour Hospital, which has 2 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT05660031 being conducted?

This trial has 4 study locations across Michigan, Oregon, Alberta, Canton of Geneva. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial